Relationship of increased circulating adrenomedullin with cardiac dysfunction, inflammation, oxidative stress and volume overload in hemodialysis patients

References

• López J, Martinez A. Cell and molecular biology of the multifunctional peptide, adrenomedullin. Int Rev Cytol 2002; 221:1–92.
   PubMed Web of Science ®Google Scholar
• Ishimura K, Nishikimi T, Akimoto K, Ono H, Kangawa K, Matsuoka H. Renoprotective effect of long-term combined treatment with adrenomedullin and omapatrilat in hypertensive rats. J Hypertens 2005;23:2287–96.
   PubMed Web of Science ®Google Scholar
• Kato J, Tsuruda T, Kita T, Kitamura K, Eto T. Adrenomedullin. A protective factor for blood vessels. Arterioscler Thromb Vasc Biol 2005;25:2480–7.
   PubMed Web of Science ®Google Scholar
• Chao J, Chao L. The role of adrsenomedullin in cardiovascular and renal function. Drug News Perspect 2002;8:511–8.
   Google Scholar
• Morimoto A, Nishikimi T, Yoshihara F, Horio T, Nagaya N, Matsuo H, Dohi K, Kangawa K. Ventricular adrenomedullin levels correlate with the extent of cardiac hypertrophy in rats. Hypertension 1999;33:1146–52.
   PubMed Web of Science ®Google Scholar
• Nishikimi T, Saito Y, Kitamura K, Ishimitsu T, Eto T, Kangawa K, Matsuo H, Omae T, Matsuoka H. Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol 1995;26:1424–31.
   PubMed Web of Science ®Google Scholar
• Miyao Y, Nishikimi T, Goto Y, Miyazaki S, Daikoku S, Morii I, Matsumoto T, Takishita S, Miyata A, Matsuo H, Kangawa K, Nonogi H. Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity. Heart 1998;79:39–44.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Horio T, Hayashi T, Nonogi H, Kitamura K, Eto T, Kangawa K, Kawano Y. Plasma adrenomedullin concentration is increased in patients with peripheral arterial occlusive disease associated with vascular inflammation. Regul Pept 2004;118:99–104.
   PubMedGoogle Scholar
• Cases A, Esforzado N, Lario S, Vera M, Lopez-Pedret J, Rivera-Fillat F, Jimenez W. Increased plasma adrenomedullin levels in haemodialysis patients with sustained hypotension. Kidney Int 2000;57:664–70.
   PubMed Web of Science ®Google Scholar
• Mallamaci F, Zoccali C, Parlongo S, Cutrupi S, Tripepi G, Postorino M. Plasma adrenomedullin during acute changes in intravascular volume in hemodialysis patients. Kidney Int 1998;54:1697–703.
   PubMed Web of Science ®Google Scholar
• Stegmayr BG. Ultrafiltration and dry weight – what are the cardiovascular effects? Artif Organs 2003;27:227–9.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P. Inflammation in end-stage renal failure: could it be treated? Nephrol Dial Transplant 2002;17:33–8.
   PubMed Web of Science ®Google Scholar
• Chosa E, Hamada H, Kitamura K, Eto T, Tajima N. Increased plasma and joint tissue adrenomedullin concentrations in patients with rheumatoid arthritis compared to those with osteoarthritis. J Rheumatol 2003;30:2553–6.
   PubMed Web of Science ®Google Scholar
• Ehlenz K, Koch B, Preuss P, Simon B, Koop I, Lang RE. High levels of circulating adrenomedullin in severe illness: correlation with C-reactive protein and evidence against the adrenal medulla as site of origin. Exp Clin Endocrinol 1997;105:156–62.
   Google Scholar
• Chun T-H, Itoh H, Saito T, Yamahara K, Doi K, Mori Y, Ogawa Y, Yamashita J, Tanaka T, Inoue M, Masatsugu K, Sawada N, Fukunaga Y, Nakao K. Oxidative stress augments secretion of endothelium-derived relaxing peptides, C-type natriuretic peptide and adrenomedullin. J Hypertens 2000; 18:575–80.
   PubMed Web of Science ®Google Scholar
• Ando K, Ito Y, Kumada M, Fujita T. Oxidative stress increases adrenomedullin mRNA levels in cultured rat vascular smooth muscle cells. Hypertens Res 1998;21:187–91.
   PubMed Web of Science ®Google Scholar
• Yoshihara F, Horio T, Nakamura S, Yoshii M, Ogata C, Nakahama H, Inenaga T, Kangawa K, Kawano Y. Adrenomedullin reflects cardiac dysfunction, excessive blood volume, and inflammation in hemodialysis patients. Kidney Int 2005; 68:1355–63.
   PubMed Web of Science ®Google Scholar
• Lewis LK, Smith MW, Yandle TG, Richards AM, Nicholls MG. Adrenomedullin (1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage. Clin Chem 1998;44:571–7.
   PubMed Web of Science ®Google Scholar
• Iwashima Y, Horio T, Takami Y, Inenaga T, Nishikimi T, Takishita S, Kawano Y. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kid Dis 2002;40: 974–82.
   PubMed Web of Science ®Google Scholar
• Rakowski H, Appleton C, Chan K, Dumesnil JG, Honos G, Jue J, Koilpillai C, Lepage S, Martin RP, Mercier LA, O'Kelly B, Prieur T, Sanfilippo A, Sasson Z, Alvarez N, Pruitt R, Thompson C, Tomlinson C. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr 1996;9: 736–60.
   PubMedGoogle Scholar
• Kanozawa K, Shimosawa T, Nagasawa R, Matsuda A, Kato H, Matsumura O, Mitarai T, Isoda K, Fujita T. Mature form of adrenomedullin is a useful marker to evaluate blood volume in hemodialysis patients. Am J Kid Dis 2002;40: 794–801.
   PubMed Web of Science ®Google Scholar
• Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001;12: 1549–57.
   PubMed Web of Science ®Google Scholar
• Nishimura M, Ushiyama M, Maruyama Y, Mabuchi H, Takahashi H, Yoshimura M. Association of human hepatocyte growth factor with hemodialysis hypotension. Hypertens Res 2000;23:581–6.
   PubMed Web of Science ®Google Scholar
• Malatino K, Mallamaci F, Benedetto FA, Bellanouova I, Cataliotti A, Tripepi G, Zoccali C. Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. Am J Kid Dis 2000;36:945–52.
   PubMed Web of Science ®Google Scholar
• Khan AI, Kato J, Ishiyama Y, Kitamura K, Kangawa K, Eto T. Secretion and clearance of mature form of adrenomedullin in human. Life Sci 1999;64:2505–9.
   PubMed Web of Science ®Google Scholar
• Kinoshita H, Fujimoto S, Kitamura K, Matsuura Y, Uezono S, Hisanaga S, Eto T. Increased plasma levels of mature adrenomedulluin in chronic glomerulonephritis. Nephron 2000;86: 333–8.
   PubMed Web of Science ®Google Scholar
• DeFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, Christenson R, Uretsky B, Smiley M, Gold J, Muniz H, Badalamenti J, Herzog C, Henrich W. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2000;290: 353–9.
   Google Scholar
• Chun TH, Itoh H, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Doi K, Inoue M, Masatsugu K, Korenaga R, Ando J, Nakao K. Shear stress augments expression of C-type natriuretic peptide and adrenomedullin. Hypertension 1997; 29:1296–302.
   PubMed Web of Science ®Google Scholar
• Galli F, Ronco C. Oxidant stress in hemodialysis. Nephron 2000; 84:1–5.
   PubMed Web of Science ®Google Scholar
• Shimosawa T, Shibagaki Y, Ishibashi K, Kitamura K, Kangawa K, Kato S, Ando K, Fujita T. Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 2000;105:106–11.
   Web of Science ®Google Scholar
• Wanner C. Altered lipid metabolism and serum lipids in renal disease and renal failure. Kopple JD, Massary SG. Kopple and Massary's nutritional management of renal disease. 2nd. Philadelphia: Lippincott Williams & Wilkins; 2004:42–55.
   Google Scholar
• Garcia-Lopez E, Carrero JJ, Suliman ME, Lindholm B, Stenvinkel P. Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis. Perit Dial Int 2007;27: S205–9.
   PubMed Web of Science ®Google Scholar
• Liu J, Rosner MH. Lipid abnormalities associated with end stage renal disease. Semin Dial 2006;19:32–40.
   PubMed Web of Science ®Google Scholar
• Kaysen GA. Hyperlipidemia in chronic kidney disease. Int J Artif Organs 2007;30:987–92.
   PubMed Web of Science ®Google Scholar
• Ariyo A, Hennekens CH, Stampfer MJ, Ridker PM. Lipoprotein (a), lipids, aspirin, and risk of myocardial infarction in the Physician's Healthy Study. J Cardiovasc Risk 1998; 5:273–8.
   PubMedGoogle Scholar
• Schlaich MP, John S, Langenfeld MR, Lackner KJ, Schmitz G, Schmieder RE. Does lipoprotein(a) impair endothelial function? J Am Coll Cardiol 1998;31:359–65.
   PubMed Web of Science ®Google Scholar
• Dangas G, Mehran R, Harpel PC, Sharma SK, Marcovina SM, Dube G, Ambrose JA, Fallon JT. Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation. J Am Coll Cardiol 1998;32:2035–42.
   PubMed Web of Science ®Google Scholar
• Yoshimoto T, Fukai N, Sato R, Sugiyama T, Ozawa N, Shichiri M, Hirata Y. Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells. Endocrinology 2004; 145:3331–7.
   PubMed Web of Science ®Google Scholar
• Kubo A, Minamino N, Isumi Y Katafuchi T, Kangawa K, Dohi K, Matsuo H. Production of adrenomedullin in macrophage cell line and peritoneal macrophage. J Biol Chem 1998;273:16730–8.
   PubMed Web of Science ®Google Scholar